NASDAQ · BDRX
Biodexa Pharmaceuticals Plc
Healthcare · Biotechnology
$1.33
Up+$0.21 (+18.75%)
Updated Sep 16, 2026, 1:12 PM
SID Score
4.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 4.12M
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- $0.60 – $11.88
- Volume
- 54.69M
- Avg. volume
- 695.79K
Price performance
BDRX price history
1M range · 20 trading sessions · Daily adjusted prices
BDRX closed at $1.33 after 20 trading sessions, down 4.32% for the selected period.
- Last close
- $1.33
- Period change
- -4.32%
- Period low
- $0.66
- Period high
- $1.39
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $1.29 | $1.43 | $1.13 | $1.33 | 54.69M |
| Sep 14, 2026 | $1.29 | $1.46 | $1.10 | $1.12 | 6.16M |
| Sep 11, 2026 | $0.88 | $1.5499 | $0.8342 | $1.30 | 142.44M |
| Sep 10, 2026 | $0.7998 | $0.845 | $0.61 | $0.6601 | 202.08K |
| Sep 9, 2026 | $0.8441 | $0.8441 | $0.79 | $0.8122 | 101.77K |
| Sep 8, 2026 | $0.82 | $0.8999 | $0.82 | $0.8308 | 95.25K |
| Sep 4, 2026 | $0.7838 | $0.86 | $0.7731 | $0.848 | 105.07K |
| Sep 3, 2026 | $0.771 | $0.7988 | $0.7623 | $0.7984 | 99.61K |
| Sep 2, 2026 | $0.758 | $0.80 | $0.7553 | $0.7849 | 58.77K |
| Sep 1, 2026 | $0.79 | $0.81 | $0.7802 | $0.7808 | 82.69K |
| Aug 31, 2026 | $0.8576 | $0.8576 | $0.78 | $0.8117 | 114.31K |
| Aug 28, 2026 | $0.87 | $0.88 | $0.8303 | $0.8681 | 110.16K |
| Aug 27, 2026 | $0.96 | $0.96 | $0.8609 | $0.90 | 280.16K |
| Aug 26, 2026 | $1.07 | $1.08 | $0.93 | $0.9773 | 1.07M |
| Aug 25, 2026 | $1.455 | $1.51 | $1.15 | $1.18 | 16.61M |
| Aug 24, 2026 | $1.22 | $1.35 | $1.18 | $1.20 | 39.53K |
| Aug 21, 2026 | $1.28 | $1.32 | $1.215 | $1.27 | 56.09K |
| Aug 20, 2026 | $1.28 | $1.3499 | $1.1701 | $1.26 | 73.26K |
| Aug 19, 2026 | $1.36 | $1.5255 | $1.25 | $1.26 | 1.21M |
| Aug 18, 2026 | $1.43 | $1.5178 | $1.34 | $1.39 | 16.72K |
Latest BDRX news
The latest Smart Investors Daily articles mentioning BDRX.
Stock researchResearch & News · SEC Filings
Loading stock research…
